fridays glp 1 (@joinfridays) • Facebook Fridays Weight Management: Medication, Pricing,

In an initial 13-week Phase 3 trial called C601, the drug reduced patients overeating, but the improvement wasnt significantly different from placebo (3)

Women with IIH and telemetric ICP monitors (n = 15) were treated with exenatide (n = 7) or placebo (n = 8) for 12 weeks

A dedicated Phase 3 liver disease trial for retatrutide is currently underway

These options range from skin-tightening technologies to surgical fat grafting and are particularly beneficial for those with significant volume loss, poor skin elasticity, or a preference for more permanent solutions

[DOI] [PubMed] [Google Scholar] 2.GBD 2015 Obesity Collaborators